Hepatic Expression of Adiponectin Receptors Increases with Non-alcoholic Fatty Liver Disease Progression in Morbid Obesity in Correlation with Glutathione Peroxidase 1-Reference-Cited by-同舟云学术

Hepatic Expression of Adiponectin Receptors Increases with Non-alcoholic Fatty Liver Disease Progression in Morbid Obesity in Correlation with Glutathione Peroxidase 1

Published:2011-01-17 Issue:4 Volume:21 Page:492-500
ISSN:0960-8923
Container-title:Obesity Surgery
language:en
Short-container-title:OBES SURG

Author:

Carazo Angel,León Josefa,Casado Jorge,Gila Ana,Delgado Sergio,Martín Ana,Sanjuan Laura,Caballero Trinidad,Muñoz Jose Antonio,Quiles Rosa,Ruiz-Extremera Angeles,Alcázar Luis Miguel,Salmerón Javier

Publisher

Springer Science and Business Media LLC

Subject

Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s11695-010-0353-2.pdf

Reference41 articles.

1. Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology. 2010;51:679–89.

2. Marceau P, Biron S, Hould FS, et al. Liver pathology and metabolic syndrome X in severe obesity. J Clin Endocrinol Metab. 1999;84:1513–7.

3. Arun J, Jhala N, Lazenby AJ, et al. Influence of liver biopsy heterogeneity and diagnosis of nonalcoholic steatohepatitis in subjects undergoing gastric bypass. Obes Surg. 2007;17:155–61.

4. Machado M, Marques-Vidal P, Cortez-Pinto H. Hepatic histology in obese patients undergoing bariatric surgery. J Hepatol. 2006;45:600–6.

5. Day CP, James OF. Steatohepatitis: a tale of two “hits”? Gastroenterology. 1998;114:842–5.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in nano-based drug delivery systems for treatment of liver cancer;Journal of Pharmaceutical Sciences;2024-08

2. The Glycyrrhiza glabra L. crude extract alleviates lipid accumulation in NAFLD by activating Nrf2 and promoting autophagy;Journal of Functional Foods;2024-05

3. The Relation of Biomarkers in Serum Non-Alcohol Fatty Liver Disease with Diabetes Mellitus Type 2 and NAFLD Obese among Adults in Basrah Governorate;Biomedicine and Chemical Sciences;2023-01-01

4. P38γ modulates the lipid metabolism in non‐alcoholic fatty liver disease by regulating the JAK–STAT signaling pathway;The FASEB Journal;2022-12-17

5. Celecoxib-mediated attenuation of non-alcoholic steatohepatitis is potentially relevant to redistributing the expression of adiponectin receptors in rats;Heliyon;2022-07